Evoke plc (LON:EVOK – Get Free Report)’s share price dropped 16.3% during mid-day trading on Wednesday . The company traded as low as GBX 57.50 ($0.74) and last traded at GBX 59.75 ($0.77). Approximately 6,331,946 shares were traded during mid-day trading, an increase of 212% from the average daily volume of 2,026,266 shares. The stock had previously closed at GBX 71.40 ($0.92).
Analyst Ratings Changes
Several equities analysts have recently commented on the stock. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank dropped their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.17) and set a “buy” rating for the company in a report on Wednesday, December 4th.
Get Our Latest Research Report on EVOK
Evoke Trading Down 17.5 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, research analysts predict that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Activity at Evoke
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,206.11). 27.00% of the stock is currently owned by corporate insiders.
Evoke Company Profile
Further Reading
- Five stocks we like better than Evoke
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Advanced Micro Devices Can Double in Price: Here’s Why
- Stock Market Upgrades: What Are They?
- How Disney’s Experiences Segment Can Restore the House of Mouse
- How to Invest in Biotech Stocks
- Healthy Energy Drinks? Celsius Holdings Building Out the Space
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.